Related Experiment Videos
Prematurity and early-onset juvenile myasthenia gravis
1Department of Pediatrics, University of Mississippi Medical Center, Jackson.
Insights
Juvenile myasthenia gravis (JMG) can manifest early, with over half of cases starting before age 3 linked to prematurity. This connection suggests prematurity may influence the development of JMG.
Area of Science:
- Neurology
- Pediatrics
- Immunology
Background:
- Juvenile myasthenia gravis (JMG) is a rare autoimmune disorder affecting neuromuscular junctions.
- Early-onset JMG, particularly before age 3, presents unique challenges in diagnosis and management.
Observation:
- A case study details a child with ocular myasthenia gravis at 16 months, progressing to bulbar and systemic weakness.
- The child's history included premature birth at 32 weeks gestation with a birth weight of 940 gm.
Findings:
- A review of documented juvenile myasthenia gravis cases revealed a significant association between early onset (before age 3) and a history of prematurity.
- Approximately 55% of juvenile myasthenia gravis patients with onset before 3 years had a history of prematurity.
Implications:
- The findings suggest a potential link between prematurity and the pathogenesis of juvenile myasthenia gravis.
- This association may offer critical insights into the underlying mechanisms of early-onset autoimmune neuromuscular disorders.
Abstract:
A child manifested ocular myasthenia gravis at age 16 months which progressed to bulbar and mild systemic weakness over a 3-year period. The medical history was significant for premature birth at 32 weeks gestation and birth weight 940 gm. A review of reported patients with juvenile myasthenia gravis with adequate documentation of the birth history, noncongenital onset, typical clinical course and diagnostic findings, and elevated titers of antiacetylcholine receptor antibodies revealed that 55% with onset before age 3 years had a history of prematurity. This association of myasthenia gravis and prematurity may provide insights to the pathogenesis of the disease.